Vaxart
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
310 Utah Ave Ste 150, South San Francisc...Phone Number
(650) 550-3500Website
www.vaxart.comRevenue
$237.3 MillionStock Symbol
VXRTIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Vaxart
Vaxart is a biotechnology company focused on developing oral vaccines delivered in pill form to help prevent infectious diseases and improve vaccine accessibility. Using its proprietary delivery platform, the company develops vaccines for conditions such as coronavirus, norovirus, influenza, and human papillomavirus, aiming to provide convenient, needle-free immunization solutions.Explore more
Vaxart Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vaxart your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Vaxart
Click to see if Vaxart had a recent Job posting/layoffs
Check out if Vaxart is spiking on competitors!
Vaxart, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Vaxart has new funding data
Product Launch: Get notified when Vaxart launches new products
Check if Vaxart has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Vaxart recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Vaxart
Compare insights from companies similar to Vaxart, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vaxart is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Vaxart is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vaxart.
Vaxart financials insights
Gather financial insights about Vaxart, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Series A
$3.3M
2012
Series B
$16.9M
2014
Stock Offering
$26.9M
2019
Multiple Rounds
$21.3M
2020
Stock Offering
$10M
Debt
$90M
Vaxart Tech Stack
A closer look at the technologies used by Vaxart
Most Recent Scoops
Person-Based
Financial Planning, Financial Reporting, Business Finance, Finance
Person-Based
Executive Moves, Earnings, Finance
Person-Based
Medical Research, Pharmaceuticals
Person-Based
Earnings, Finance
Person-Based
Vaxart News & Media
Vaxart Files Preliminary Proxy Statement and Issues Open Letter to Shareholders
Company is Entering a Pivotal Phase to Demonstrate Value of its Unique Oral Vaccine PlatformVaxart, Inc. (VXRT) Q1 2026 Earnings Call Transcript
Vaxart, Inc. (VXRT) Q1 2026 Earnings Call May 8, 2026 4:30 PM EDTCompany ParticipantsSteven Lo - President, CEO & DirectorJames Cummings - Chief Medical...Vaxart to Host Stockholder Fireside Chat on May 8 at 4:30 p.m. ET
Company to report first quarter 2026 financial results on May 7Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors
Appointment strengthens Board’s clinical development and regulatory expertise as Vaxart advances its oral vaccine platform
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vaxart
Sign Up For FreeTo access detailed company insights
Vaxart is a biotechnology company focused on developing oral vaccines delivered in pill form to help prevent infectious diseases and improve vaccine accessibility. Using its proprietary delivery platform, the company develops vaccines for conditions such as coronavirus, norovirus, influenza, and human papillomavirus, aiming to provide convenient, n... Read More
